Skip to content

Effect of Circadian Rhythm on Remimazolam ED50 and ED95 in Patients Undergoing Painless Gastroscopy

Effect of Circadian Rhythm on Remimazolam ED50 and ED95 in Patients Undergoing Painless Gastroscopy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082944
Enrollment
Unknown
Registered
2024-04-11
Start date
2024-04-12
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastroscopy patients

Interventions

A group:Anesthesia induction was performed using Remazolam and Alfentanil at a dose of 5ug/kg, with Remazolam administered for 10 seconds. Using a biased coin design up and down sequential method (BCD
P group:Anesthesia induction was performed using Remazolam and Alfentanil at a dose of 5ug/kg, with Remazolam administered for 10 seconds. Using a biased coin design up and down sequential method (BCD

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1) Painless gastroscopy under intravenous anesthesia 2) ASA classification I-II 3) Aged 18-60 years old 4) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Allergy to benzodiazepines and opioids 2) Sleep disorders 3) Long-term history of taking sedative and analgesic drugs 4) Pathological obesity/obstructive sleep apnea 5) Acute upper respiratory tract infection 6) Asthma attack period 7) Uncontrolled severe hypertension 8) Unstable angina 9) Severe liver dysfunction 10) Acute upper gastrointestinal bleeding accompanied by shock 11) Severe anemia 12) Gastrointestinal obstruction accompanied by gastric content retention 13) Schizophrenia and severe depression.

Design outcomes

Primary

MeasureTime frame
Depth of anesthesia;Sleep quality;

Secondary

MeasureTime frame
Remimazolam dosage;Alfentanil dosage;Alert time;

Countries

China

Contacts

Public ContactDan Cheng

The First Affiliated Hospital of Zhengzhou University

chengdan0607@163.com+86 371 6627 8576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026